IL141061A0 - Bpc-1 a secreted brain specific protein expressed and sectreted by prostate and bladder cancer cells - Google Patents

Bpc-1 a secreted brain specific protein expressed and sectreted by prostate and bladder cancer cells

Info

Publication number
IL141061A0
IL141061A0 IL14106199A IL14106199A IL141061A0 IL 141061 A0 IL141061 A0 IL 141061A0 IL 14106199 A IL14106199 A IL 14106199A IL 14106199 A IL14106199 A IL 14106199A IL 141061 A0 IL141061 A0 IL 141061A0
Authority
IL
Israel
Prior art keywords
bpc
cancer cells
expressed
bladder cancer
secreted
Prior art date
Application number
IL14106199A
Other languages
English (en)
Original Assignee
Urogenesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urogenesys Inc filed Critical Urogenesys Inc
Publication of IL141061A0 publication Critical patent/IL141061A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL14106199A 1998-08-10 1999-08-10 Bpc-1 a secreted brain specific protein expressed and sectreted by prostate and bladder cancer cells IL141061A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9598298P 1998-08-10 1998-08-10
PCT/US1999/018250 WO2000009691A2 (en) 1998-08-10 1999-08-10 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells

Publications (1)

Publication Number Publication Date
IL141061A0 true IL141061A0 (en) 2002-02-10

Family

ID=22254489

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14106199A IL141061A0 (en) 1998-08-10 1999-08-10 Bpc-1 a secreted brain specific protein expressed and sectreted by prostate and bladder cancer cells
IL141061A IL141061A (en) 1998-08-10 2001-01-24 Protein useful as a marker for cancer and method for diagnosing prostate or bladder cancer using said protein

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL141061A IL141061A (en) 1998-08-10 2001-01-24 Protein useful as a marker for cancer and method for diagnosing prostate or bladder cancer using said protein

Country Status (9)

Country Link
US (4) US6277972B1 (xx)
EP (1) EP1104462B1 (xx)
JP (2) JP4282906B2 (xx)
AT (1) ATE350474T1 (xx)
AU (1) AU756452B2 (xx)
CA (1) CA2338982C (xx)
DE (1) DE69934694T2 (xx)
IL (2) IL141061A0 (xx)
WO (1) WO2000009691A2 (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1012259E (pt) * 1997-06-04 2009-11-06 Oxford Biomedica Ltd Vector dirigido a tumor
US7276488B2 (en) * 1997-06-04 2007-10-02 Oxford Biomedica (Uk) Limited Vector system
US7635687B2 (en) * 1997-06-04 2009-12-22 Oxford Biomedica (Uk) Limited Vector system
US8096872B2 (en) * 1998-06-22 2012-01-17 Igt Method and apparatus for providing electronic credits at a gaming device without first requiring payment therefor
US6277972B1 (en) 1998-08-10 2001-08-21 Urogenesys, Inc. BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
AU5416700A (en) * 1999-05-20 2000-12-12 Fahri Saatcioglu Differentially expressed genes in prostate cancer
US7611892B2 (en) * 2000-03-24 2009-11-03 President And Fellows Of Harvard College Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
US7189565B2 (en) * 2001-03-23 2007-03-13 Fahri Saatcioglu Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
EP1301533A1 (de) * 2000-07-07 2003-04-16 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Tumorassoziiertes antigen (b345), gekennzeichnet durch eine aminosäuresequenz wie in seq. id. no. 4
US7390263B1 (en) * 2000-10-19 2008-06-24 Igt Method of implementing cashless play of gaming devices interconnected by a computer network
GB0126378D0 (en) * 2001-11-02 2002-01-02 Oxford Biomedica Ltd Antigen
WO2003068967A2 (en) * 2002-02-18 2003-08-21 Lynkeus Bio Tech Gmbh Novel retina specific human proteins wdr17, net01, protein kinase a203, protein kinase mak a194, protein a105, protein a106 and c12orf3variants
US20040018580A1 (en) * 2002-05-10 2004-01-29 Chai Karl X. Synthetic substrates for prostasin
AU2004207233C1 (en) * 2003-01-24 2008-04-24 Agensys, Inc. Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer
ATE504649T1 (de) * 2003-02-07 2011-04-15 Univ California Nell-peptidexpressionssysteme und knochenbildende aktivität des nell-peptids
WO2005027845A2 (en) * 2003-09-18 2005-03-31 Alexion Pharmaceuticals, Inc. Method of identifying cell surface molecules involved in cancer metastasis
KR101866623B1 (ko) * 2005-11-28 2018-07-04 젠맵 에이/에스 재조합 １가 항체 및 그의 제조 방법
WO2008013541A2 (en) * 2006-07-25 2008-01-31 Walker Digital, Llc Method and apparatus for conditional payouts in a gaming device
AU2008251877A1 (en) * 2007-05-08 2008-11-20 Picobella Llc Methods for diagnosing and treating prostate and lung cancer
JP2009245920A (ja) * 2008-03-11 2009-10-22 Sony Corp 燃料電池、電子機器および燃料電池用緩衝液

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
DE69434470T2 (de) * 1993-02-09 2006-06-22 The Johns Hopkins University School Of Medicine Zellkernmatrixproteine
EP0904397A4 (en) * 1996-04-16 2003-01-29 Smithkline Beecham Corp METHOD FOR DETECTION OF THE PROSTATE SPECIFIC ANTIGEN USED FOR MONITORING AND DIAGNOSING PROSTATE CANCER
US6277972B1 (en) 1998-08-10 2001-08-21 Urogenesys, Inc. BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
WO2002059275A2 (en) 2001-01-08 2002-08-01 Millennium Pharmaceuticals, Inc. 39362, a novel human cub domain-containing protein family member and uses thereof
CA2446437A1 (en) 2001-05-03 2002-11-14 Curagen Corporation Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
AU2002362586A1 (en) 2001-07-17 2003-04-07 Incyte Genomics, Inc. Receptors and membrane-associated proteins

Also Published As

Publication number Publication date
DE69934694T2 (de) 2007-10-04
JP4637055B2 (ja) 2011-02-23
CA2338982C (en) 2011-03-15
JP2006320324A (ja) 2006-11-30
US8003758B2 (en) 2011-08-23
US20020161212A1 (en) 2002-10-31
AU756452B2 (en) 2003-01-16
CA2338982A1 (en) 2000-02-24
US7785811B2 (en) 2010-08-31
WO2000009691A3 (en) 2000-05-11
EP1104462B1 (en) 2007-01-03
IL141061A (en) 2009-12-24
ATE350474T1 (de) 2007-01-15
WO2000009691A9 (en) 2000-08-03
US20050148012A1 (en) 2005-07-07
JP2002522076A (ja) 2002-07-23
EP1104462A2 (en) 2001-06-06
JP4282906B2 (ja) 2009-06-24
AU5556199A (en) 2000-03-06
DE69934694D1 (de) 2007-02-15
US6277972B1 (en) 2001-08-21
WO2000009691A2 (en) 2000-02-24
US20100168027A1 (en) 2010-07-01

Similar Documents

Publication Publication Date Title
IL141061A0 (en) Bpc-1 a secreted brain specific protein expressed and sectreted by prostate and bladder cancer cells
IL149046A0 (en) 36p6d5: secreted tumor antigen
NZ335531A (en) Composition and methods of producing human cartilage tissue
TW200728465A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2001287639A1 (en) Trp8, trp9 and trp10, markers for cancer
MXPA03001645A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
MXPA02000192A (es) Composiciones y metodos para la terapia y diagnostico de cancer de pulmon.
MXPA04002593A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
MXPA03011985A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
HUP0203968A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
PL356846A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
IL146125A0 (en) Novel quinones as disease therapies
PT1699480E (pt) AGENTE TERAPjUTICO ANTI-TUMORAL ALOGÉNICO
BRPI0416686A (pt) composição para obter benefìcios na pele usando intermediários metabólicos celulares chave.
MXPA03001643A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
EP1546182A4 (en) COMPOSITIONS AND METHOD FOR DIAGNOSING AND TREATING TUMORS
ATE309382T1 (de) Rekombinante adenovirenvektoren zur gentherapie der menschlichen krebse
WO2002067771A3 (en) Chemokine receptors and disease
MXPA02011563A (es) Composicionesy metodos para la terapia y diagnostico de cancer de seno.
WO2003013431A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
YU63702A (sh) Novo antitelo sa specifičnošću za rak debelog creva
WO2000012709A3 (en) Phelix: a testis-specific protein expressed in cancer
WO2001062925A3 (en) 103p2d6: tissue specific protein highly expressed in various cancers
MXPA03001644A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.